Cargando…

Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?

Tuberculosis (TB), one of the top ten causes of death globally induced by the infection of Mycobacterium tuberculosis (Mtb), remains a grave public health issue worldwide. With almost one-third of the world’s population getting infected by Mtb, between 5% and 10% of these infected individuals are pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Jiaojiao, Liu, Yilin, Ma, Yuhe, Yang, Fen, Ruan, Yongdui, Xu, Jun-Fa, Pi, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458399/ https://www.ncbi.nlm.nih.gov/pubmed/37631310 http://dx.doi.org/10.3390/pharmaceutics15082096

Ejemplares similares

Promising Roles of Circular RNAs as Biomarkers and Targets for Potential Diagnosis and Therapy of Tuberculosis
por: Huang, Yifan, et al.
Publicado: (2022)

Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?
por: Chen, Haorong, et al.
Publicado: (2023)

Advances of Cobalt Nanomaterials as Anti-Infection Agents, Drug Carriers, and Immunomodulators for Potential Infectious Disease Treatment
por: Ma, Yuhe, et al.
Publicado: (2022)

Long Non-coding RNAs in Tuberculosis: From Immunity to Biomarkers
por: Zhang, Xianyi, et al.
Publicado: (2022)

Advances of MnO(2) nanomaterials as novel agonists for the development of cGAS-STING-mediated therapeutics
por: Zhang, Tangxin, et al.
Publicado: (2023)

Screening of Long Non-coding RNAs Biomarkers for the Diagnosis of Tuberculosis and Preliminary Construction of a Clinical Diagnosis Model
por: Chen, Juli, et al.
Publicado: (2022)

Trends and recent progresses of selenium nanoparticles as novel autophagy regulators for therapeutic development
por: Chen, Dongsheng, et al.
Publicado: (2023)

Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics
por: Huang, Yuhe, et al.
Publicado: (2023)

Advances in Brain Metastases Diagnosis: Non-coding RNAs As Potential Biomarkers
por: Eraky, Akram M
Publicado: (2023)

Advances with Long Non-Coding RNAs in Alzheimer’s Disease as Peripheral Biomarker
por: Garofalo, Maria, et al.
Publicado: (2021)

Identification of long non-coding RNAs biomarkers for early diagnosis of myocardial infarction from the dysregulated coding-non-coding co-expression network
por: Sun, Chaoyu, et al.
Publicado: (2016)

Recent Advances of MicroRNAs, Long Non-coding RNAs, and Circular RNAs in Preeclampsia
por: Chen, Ailing, et al.
Publicado: (2021)

The targeting of non-coding RNAs by curcumin: Facts and hopes for cancer therapy
por: Liu, Yun, et al.
Publicado: (2019)

Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition
por: Lin, Wensen, et al.
Publicado: (2023)

Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope?
por: Helsmoortel, Hetty, et al.
Publicado: (2018)

Current progress of functional nanobiosensors for potential tuberculosis diagnosis: The novel way for TB control?
por: Yang, Xuran, et al.
Publicado: (2022)

Biomarkers for Treatment Monitoring in Tuberculosis: A New Hope
por: Babu, Subash
Publicado: (2017)

Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis
por: Yuan, Donghong, et al.
Publicado: (2021)

Integrated analysis of long non-coding RNAs and mRNA profiles reveals potential sex-dependent biomarkers of bevacizumab/erlotinib response in advanced lung cancer
por: Tu, Chao, et al.
Publicado: (2020)

Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance
por: Shen, Ling, et al.
Publicado: (2023)

Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma
por: Wu, Yanhua, et al.
Publicado: (2022)

Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis
por: Jiang, Yong, et al.
Publicado: (2023)

The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development
por: Jiang, Fengru, et al.
Publicado: (2019)

microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome
por: Tamaddon, Mona, et al.
Publicado: (2022)

Exosomal long non-coding RNAs as biomarkers in human diseases
por: Kelemen, Evelyn, et al.
Publicado: (2019)

Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis
por: Wang, Chuqiao, et al.
Publicado: (2021)

Corrigendum: Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma
por: Wu, Yanhua, et al.
Publicado: (2022)

Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer
por: Wang, Yizhi, et al.
Publicado: (2020)

Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing
por: Bian, Bingxian, et al.
Publicado: (2022)

The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma
por: Zhi, Feng, et al.
Publicado: (2015)

Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis
por: Di Mauro, Stefania, et al.
Publicado: (2020)

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
por: Pi, Ya-Nan, et al.
Publicado: (2021)

Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy
por: Wu, Men, et al.
Publicado: (2020)

Differential expression profiles of long non-coding RNAs as potential biomarkers for the early diagnosis of acute myocardial infarction
por: Li, Ling, et al.
Publicado: (2017)

Long non‐coding RNAs and their targets as potential biomarkers in breast cancer
por: Khalid, Maryam, et al.
Publicado: (2021)

Long non-coding RNAs as biomarkers and therapeutic targets for ischemic stroke
por: Sufianova, Galina, et al.
Publicado: (2022)

Exosomal Long Non-coding RNAs Serve as Biomarkers for Liver Disease
por: Yang, Zixuan, et al.
Publicado: (2023)

The Role of microRNAs and Long Non-Coding RNAs in the Regulation of the Immune Response to Mycobacterium tuberculosis Infection
por: Kundu, Manikuntala, et al.
Publicado: (2021)

Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
por: Pi, Ya-Nan, et al.
Publicado: (2022)

Integrated analysis of long non-coding RNAs and mRNAs associated with peritendinous fibrosis()
por: Zheng, Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_to1354n5sucij2togbes0u9stq